Helicobacter pylori as an oncogenic pathogen, revisited

Expert Reviews in Molecular Medicine

Volumn 19, Issue , 2017, Pages

  Miftahussurur, Muhammad ^a,b,c   Yamaoka, Yoshio ^a,b   Graham, David Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b OITA UNIVERSITY   (Japan)

^c AIRLANGGA UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; ONCOPROTEIN; VIRULENCE FACTOR;

ANIMAL; CELL TRANSFORMATION; COMPLICATION; DISEASE PREDISPOSITION; GENETICS; GENOMIC INSTABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; MICROFLORA; NEOPLASM; PATHOLOGY; PHYSIOLOGY; RESEARCH;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE SUSCEPTIBILITY; GENOMIC INSTABILITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOTA; NEOPLASMS; ONCOGENE PROTEINS; RESEARCH; VIRULENCE FACTORS;

EID: 85015694261     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/erm.2017.4     Document Type: Review

References (118)

1. Faber K. (1935) Gastritis and its consequences. Paris: Oxford University Press
2. Graham D.Y. (2014) History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World Journal of Gastroenterology 20, 5191-5204
3. Graham D.Y. and Asaka M. (2010) Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. Journal of Gastroenterology 45, 1-8
4. Baron J.H. and Sonnenberg A. (2002) Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries. Gut 50, 568-570
5. Marshall B.J. and Warren J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori (1994) Infection with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61. Lyon, France: International Agency for Research on Cancer, 177-240
7. Yamaoka Y. (2010) Mechanisms of disease: Helicobacter pylori virulence factors. Nature Reviews Gastroenterology & Hepatology 7, 629-641
8. Graham D.Y. (2015) Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology 148, 719-731 e713
9. Kamada T. et al., (2015) Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 20, 192-198
10. Wang C., Weber A. and Graham D.Y. (2015) Age, period, and cohort effects on gastric cancer mortality. Digestive Diseases and Sciences 60, 514-523
11. Yamaoka Y. and Graham D.Y. (2014) Helicobacter pylori virulence and cancer pathogenesis. Future Oncology 10, 1487-1500
12. Correa P. (1984) Chronic gastritis as a cancer precursor. Scandinavian Journal of Gastroenterology. Supplement 104, 131-136
13. Ruddell W.S. et al., (1976) Gastric-juice nitrite. A risk factor for cancer in the hypochlorhydric stomach? Lancet 2, 1037-1039
14. Lee Y.C. et al., (2016) Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 150, 1113-1124 e1115
15. Lee Y.C. et al., (2016) Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations. Gut and Liver 10, 12-26
16. Graham D.Y. and Shiotani A. (2005) The time to eradicate gastric cancer is now. Gut 54, 735-738
17. Hanada K. and Graham D.Y. (2014) Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Review of Anticancer Therapy 14, 947-954
18. Xue H. et al., (2010) Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. Journal of Gastroenterology and Hepatology 25, 1604-1617
19. Figueiredo C. et al., (2002) Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. Journal of the National Cancer Institute 94, 1680-1687
20. Sgouros S.N. and Bergele C. (2006) Clinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment? Postgraduate Medical Journal 82, 338-342
21. Lu H., Yamaoka Y. and Graham D.Y. (2005) Helicobacter pylori virulence factors: facts and fantasies. Current Opinion in Gastroenterology 21, 653-659
22. Censini S. et al., (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proceedings of the National Academy of Sciences of the United States of America 93, 14648-14653
23. Asahi M. et al., (2000) Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. Journal of Experimental Medicine 191, 593-602
24. van Doorn L.J. et al., (1998) Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115, 58-66
25. Huang J.Q. et al., (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125, 1636-1644
26. Parsonnet J. et al., (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301
27. Brandt S. et al., (2005) NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proceedings of the National Academy of Sciences of the United States of America 102, 9300-9305
28. Crabtree J.E. et al., (1995) Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. Journal of Clinical Pathology 48, 41-45
29. Yamaoka Y. et al., (1996) Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110, 1744-1752
30. Backert S. et al., (2001) Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Molecular Microbiology 42, 631-644
31. Franco A.T. et al., (2008) Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Research 68, 379-387
32. Watanabe T. et al., (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115, 642-648
33. Franco A.T. et al., (2005) Activation of beta-catenin by carcinogenic Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America 102, 10646-10651
34. Sugimoto M. et al., (2009) Gastric mucosal interleukin-17 and-18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Science 100, 2152-2159
35. Sugimoto M. et al., (2011) Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. Journal of Gastroenterology and Hepatology 26, 1677-1684
36. Nozaki K. et al., (2002) Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Japanese Journal of Cancer Research 93, 374-381
37. Cao X. et al., (2004) Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer Science 95, 872-877
38. Shimizu N. et al., (2000) Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Research 60, 1512-1514
39. Cai X. et al., (2005) Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 128, 1937-1952
40. Tsukamoto T. et al., (2013) Helicobacter pylori infection and gastric carcinogenesis in rodent models. Seminars in Immunopathology 35, 177-190
41. Freedberg D.E., Abrams J.A. and Wang T.C. (2014) Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori? Journal of the National Cancer Institute 106, dju148
42. Cao X. et al., (2002) Earlier Helicobacter pylori infection increases the risk for the N-methyl-N-nitrosourea-induced stomach carcinogenesis in Mongolian gerbils. Japanese Journal of Cancer Research 93, 1293-1298
43. Nozaki K. et al., (2003) Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Science 94, 235-239
44. Ohnishi N. et al., (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proceedings of the National Academy of Sciences of the United States of America 105, 1003-1008
45. Hayakawa Y. et al., (2013) Mouse models of gastric cancer. Cancers (Basel) 5, 92-130
46. Zhang W., Lu H. and Graham D.Y. (2014) An Update on Helicobacter pylori as the cause of Gastric Cancer. Gastrointestinal Tumors 1, 155-165
47. Hatakeyama M. (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature Reviews. Cancer 4, 688-694
48. Higashi H. et al., (2002) Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proceedings of the National Academy of Sciences of the United States of America 99, 14428-14433
49. Satomi S. et al., (2006) Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. Journal of Gastroenterology 41, 668-673
50. Abe T. et al., (2011) Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: an immunohistochemical study of East-Asian-type CagA. Journal of Gastroenterology and Hepatology 26, 688-693
51. Matsunari O. et al., (2012) Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. Journal of Clinical Microbiology 50, 876-883
52. Vilaichone R.K. et al., (2004) Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 9, 453-459
53. Matsuhisa T. et al., (2015) Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection. World Journal of Gastroenterology 21, 8408-8417
54. Xia Y. et al., (2009) A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS ONE 4, e7736
55. Yamaoka Y. et al., (1998) Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. Journal of Clinical Microbiology 36, 2258-2263
56. Yamaoka Y. et al., (1999) Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117, 342-349
57. Argent R. et al., (2004) Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127, 514-523
58. Azuma T. et al., (2002) Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. Journal of Infectious Diseases 186, 1621-1630
59. Naito M. et al., (2006) Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130, 1181-1190
60. Nagase L. et al., (2015) Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis. Scientific Reports 5, 15749
61. Yamaoka Y., Reddy R. and Graham D.Y. (2010) Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. Journal of Clinical Microbiology 48, 2550-2551
62. Atherton J.C. et al., (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. Journal of Biological Chemistry 270, 17771-17777
63. Cover T.L. et al., (1994) Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. Journal of Biological Chemistry 269, 10566-10573
64. McClain M.S. et al., (2001) A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. Journal of Bacteriology 183, 6499-6508
65. Cover T.L. and Blanke S.R. (2005) Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nature Reviews. Microbiology 3, 320-332
66. Radin J.N. et al., (2014) Role of connexin 43 in Helicobacter pylori VacA-induced cell death. Infection and Immunity 82, 423-432
67. Memon A.A. et al., (2014) Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study. Journal of Clinical Microbiology 52, 2984-2989
68. Saxena A. et al., (2011) Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease. Indian Journal of Medical Research 133, 514-520
69. Chomvarin C. et al., (2008) Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. International Journal of Infectious Diseases 12, 30-36
70. Sugimoto M. and Yamaoka Y. (2009) The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clinical Microbiology and Infection 15, 835-842
71. González C.A. et al., (2011) Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. American Journal of Gastroenterology 106, 867-874
72. Rhead J.L. et al., (2007) A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133, 926-936
73. Ogiwara H. et al., (2009) Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. Journal of Clinical Microbiology 47, 3493-3500
74. Bakhti S.Z. et al., (2016) Relevance of Helicobacter pylori vacA 3′-end region polymorphism to gastric cancer. Helicobacter 21, 305-316
75. Hussein N.R. et al., (2008) Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. Journal of Clinical Microbiology 46, 1774-1779
76. Basso D. et al., (2008) Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135, 91-99
77. Yordanov D. et al., (2012) Significance of Helicobacter pylori vacA intermediate region genotyping-a Bulgarian study. Diagnostic Microbiology and Infectious Disease 74, 253-257
78. Ogiwara H., Graham D.Y. and Yamaoka Y. (2008) vacA i-region subtyping. Gastroenterology 134, 1267; author reply 1268
79. Yamaoka Y. et al., (1998) Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 3, 241-253
80. Backert S., Clyne M. and Tegtmeyer N. (2011) Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Communication and Signaling 9, 28
81. Yamaoka Y. et al., (2002) Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 123, 414-424
82. Yamaoka Y. et al., (2006) Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55, 775-781
83. Liu J. et al., (2013) Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infectious Diseases 13, 555
84. Sheu B.S. et al., (2003) Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 52, 927-932
85. Moonens K. et al., (2016) Structural insights into polymorphic ABO glycan binding by Helicobacter pylori. Cell Host & Microbe 19, 55-66
86. Rad R. et al., (2002) The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. Journal of Immunology 168, 3033-3041
87. Hill A.B. (1965) The environment and disease: association or causation? Proceedings of the Royal Society of Medicine 58, 295-300
88. Kikuchi S. (2002) Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 5, 6-15
89. Hanada K. et al., (2014) Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infection and Immunity 82, 4182-4189
90. Shiotani A., Cen P. and Graham D.Y. (2013) Eradication of gastric cancer is now both possible and practical. Seminars in Cancer Biology 23, 492-501
91. Okazaki I.M. et al., (2003) Constitutive expression of AID leads to tumorigenesis. Journal of Experimental Medicine 197, 1173-1181
92. Shimizu T. et al., (2015) Molecular pathogenesis of Helicobacter pylori-related gastric cancer. Gastroenterology Clinics of North America 44, 625-638
93. Hollstein M. et al., (1991) p53 mutations in human cancers. Science 253, 49-53
94. Matsumoto Y. et al., (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Natural Medicines 13, 470-476
95. Toller I.M. et al., (2011) Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America 108, 14944-14949
96. Xu Y. and Price B.D. (2011) Chromatin dynamics and the repair of DNA double strand breaks. Cell Cycle 10, 261-267
97. Mantovani A. (2010) Molecular pathways linking inflammation and cancer. Current Molecular Medicine 10, 369-373
98. Nardone G. et al., (2007) Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Digestive Diseases 25, 225-229
99. Maekita T. et al., (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clinical Cancer Research 12, 989-995
100. Fischle W., Wang Y. and Allis C.D. (2003) Histone and chromatin cross-talk. Current Opinion in Cell Biology 15, 172-183
101. Barbarotto E., Schmittgen T.D. and Calin G.A. (2008) MicroRNAs and cancer: profile, profile, profile. International Journal of Cancer 122, 969-977
102. Zhang Z. et al., (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation 88, 1358-1366
103. Petrocca F. et al., (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13, 272-286
104. Nagata N. et al., (2014) Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication. Journal of Gastroenterology 49, 427-435
105. Shiotani A. et al., (2012) Eradication of H. pylori did not improve abnormal sonic hedgehog expression in the high risk group for gastric cancer. Digestive Diseases and Sciences 57, 643-649
106. Shiotani A. et al., (2012) H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. Journal of Gastroenterology 47, 988-998
107. Take S. et al., (2007) Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. Journal of Gastroenterology 42 (Suppl 17), 21-27
108. Shiotani A., Haruma K. and Graham D.Y. (2014) Metachronous gastric cancer after successful Helicobacter pylori eradication. World Journal of Gastroenterology 20, 11552-11559
109. Graham D.Y. (2014) Helicobacter pylori eradication and metachronous gastric cancer. Clinical Gastroenterology and Hepatology 12, 801-803
110. Shiotani A., Matsueda A. and Graham D.Y. (2015) Changing the natural history of metachronous gastric cancer after H. pylori eradication. Japanese Journal of Helicobacter Research 16, 52-60
111. Yoon S.B. et al., (2014) Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 19, 243-248
112. Comfort M.W. (1951) Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Annals of Internal Medicine 34, 1331-1348
113. Forsythe S.J. et al., (1988) Nitrate-and nitrite-reducing bacteria in the achlorhydric stomach. Journal of Medical Microbiology 25, 253-259
114. Osato M.S. et al., (1998) Microflora of gastric biopsies from patients with duodenal ulcer and gastric cancer: a comparative study of patients from Korea, Colombia, and the United States. Digestive Diseases and Sciences 43, 2291-2295
115. Rugge M. et al., (2012) Autoimmune gastritis: histology phenotype and OLGA staging. Alimentary Pharmacology & Therapeutics 35, 1460-1466
116. Gaddy J.A. et al., (2013) High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infection and Immunity 81, 2258-2267
117. Graham D.Y., Shiotani A. and El-Zimaity H.M. (2006) Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointestinal Endoscopy 64, 686-690
118. Chang W.J. et al., (2014) Inflammation-related factors predicting prognosis of gastric cancer. World Journal of Gastroenterology 20, 4586-4596